HBV / HDV Multiplex PCR Test in Karachi at Dr. Essa Lab

HBV / HDV Multiplex PCR at Dr. Essa Lab

The HBV / HDV Multiplex PCR test is an advanced molecular diagnostic assay designed for the simultaneous detection and quantification of Hepatitis B Virus (HBV) DNA and Hepatitis D Virus (HDV) RNA in a patient’s blood. Hepatitis B is a highly prevalent double-stranded DNA virus that infects hepatocytes, leading to acute or chronic liver disease. Hepatitis D, also known as the delta virus, is a defective single-stranded RNA satellite virus that can only replicate in the presence of HBV, utilizing the Hepatitis B surface antigen (HBsAg) to assemble its outer envelope. Consequently, HDV infection occurs either as a co-infection alongside acute HBV or as a superinfection in individuals who are already chronic carriers of HBV. This multiplex polymerase chain reaction (PCR) test represents a critical advancement in molecular diagnostics, offering a rapid, highly sensitive, and specific method to identify both viral genomes in a single clinical run.

Using state-of-the-art real-time PCR technology, the assay amplifies target genetic sequences unique to HBV and HDV. This dual-target amplification allows clinical pathologists and hepatologists to assess the precise viral load of both pathogens simultaneously. The clinical importance of this test cannot be overstated; HDV superinfection in chronic HBV patients is associated with the most severe form of chronic viral hepatitis, characterized by a rapid progression to liver cirrhosis, hepatic decompensation, and an elevated risk of hepatocellular carcinoma (HCC). By utilizing the HBV / HDV Multiplex PCR test at Dr. Essa Lab, clinicians can obtain accurate baseline viral load measurements, which are essential for establishing a definitive diagnosis, formulating targeted antiviral treatment strategies, and monitoring therapeutic efficacy over time.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the highest level of accuracy and prevent any potential pre-analytical errors, patients are advised to follow these preparation guidelines before undergoing the HBV / HDV Multiplex PCR test:

• No Fasting Required: Fasting is generally not mandatory for this molecular test. Patients can eat and drink normally prior to sample collection.
• Medication Disclosure: It is crucial to inform your prescribing physician and the laboratory staff of any antiviral medications, immunomodulators, or immunosuppressive therapies you are currently taking, as these can directly impact viral replication and the resulting viral load.
• Hydration: Staying well-hydrated is highly recommended, as it facilitates easier venipuncture and ensures adequate blood flow during the collection process.
• Avoid Strenuous Exercise: Patients should avoid vigorous physical activity immediately before the blood draw to maintain baseline physiological conditions.
• Carry Medical Records: Bringing previous hepatitis serology reports, liver function test (LFT) results, or prior PCR reports can assist the consulting pathologist in clinical correlation.

During the Procedure

The collection of the clinical specimen for the HBV / HDV Multiplex PCR test is a standard, minimally invasive procedure performed by highly trained phlebotomists at Dr. Essa Lab:

• Patient Positioning: The patient is comfortably seated, and the phlebotomist inspects the antecubital fossa (the inner bend of the elbow) to locate a suitable vein.
• Aseptic Technique: The skin over the selected vein is thoroughly cleansed with an antiseptic solution (typically 70% isopropyl alcohol) to eliminate surface bacteria and prevent sample contamination.
• Venipuncture: A sterile, single-use needle attached to a vacuum collection tube (typically containing EDTA or a serum separator gel) is inserted into the vein. A small volume of blood (approximately 3 to 5 mL) is drawn.
• Sensation and Duration: Patients may feel a brief, mild pinch as the needle enters the skin. The entire blood collection process is completed in less than two minutes.
• Post-Collection Care: Once the needle is withdrawn, gentle pressure is applied to the puncture site with a sterile cotton ball, followed by the application of an adhesive bandage to prevent bruising or minor bleeding.
• Sample Processing: The collected blood sample is immediately labeled with unique patient identifiers and transported to the molecular diagnostics division under strict temperature-controlled conditions to preserve the integrity of the viral DNA and RNA.

When is a HBV / HDV Multiplex PCR Performed?

Chronic Hepatitis B Monitoring

Physicians frequently request this multiplex PCR test for patients diagnosed with chronic Hepatitis B. Monitoring the HBV viral load is essential to evaluate the phase of chronic infection, assess the risk of disease progression, and determine the necessity of initiating nucleoside or nucleotide analog therapy. Simultaneous HDV screening is recommended for all HBV-positive individuals to rule out underlying silent co-infections.

Suspected HDV Co-infection or Superinfection

When a patient with known chronic Hepatitis B experiences a sudden, unexplained clinical deterioration, a rapid rise in liver enzymes (such as ALT and AST), or signs of acute hepatic failure, an HDV superinfection is highly suspected. The multiplex PCR test is performed immediately to detect HDV RNA, enabling clinicians to differentiate between an HBV disease flare and a newly acquired HDV infection.

Evaluation of Unexplained Liver Disease Progression

In cases where patients present with rapidly progressing liver fibrosis, early-onset cirrhosis, or portal hypertension without an obvious cause, this test is utilized to identify if a dual viral infection is driving the accelerated hepatic damage. Identifying HDV is critical because it is known to suppress HBV replication, meaning standard HBV tests alone might underestimate the total viral burden and disease severity.

Assessment Prior to Initiating Antiviral Therapy

Before starting any potent antiviral regimen, particularly pegylated interferon-alpha or newer entry inhibitors like bulevirtide, a baseline quantitative HBV / HDV Multiplex PCR is mandatory. These baseline values serve as the reference point against which all subsequent viral load measurements are compared to evaluate how well the patient is responding to the prescribed treatment.

Monitoring Response to Antiviral Treatment

During the course of antiviral therapy, periodic multiplex PCR testing is performed to monitor the suppression of both viral genomes. A significant decline in viral load indicates a favorable response to treatment, while persistent viremia or a rebound in viral levels can alert clinicians to potential drug resistance, poor patient compliance, or the need for therapeutic modification.

What Does a HBV / HDV Multiplex PCR Detect?

The HBV / HDV Multiplex PCR test is designed to detect, quantify, and evaluate several critical molecular and clinical parameters. These findings provide a comprehensive overview of the viral dynamics within the patient’s system:

• Presence of HBV DNA: Confirms the active replication of the Hepatitis B Virus in the host’s hepatocytes.
• HBV Viral Load Quantification: Measures the exact concentration of HBV DNA in International Units per milliliter (IU/mL) or copies/mL.
• Presence of HDV RNA: Confirms active infection and replication of the Hepatitis D Virus.
• HDV Viral Load Quantification: Measures the precise concentration of HDV RNA, indicating the severity of the delta virus infection.
• Co-infection Status: Identifies the simultaneous acquisition of both HBV and HDV, which often presents as severe acute hepatitis.
• Superinfection Status: Detects HDV infection in a patient with pre-existing chronic HBV, which typically leads to chronic HDV in 90% of cases.
• Lower Limit of Detection (LOD): Verifies the minimum concentration of viral nucleic acids that the assay can reliably detect, ensuring high sensitivity.
• Linear Range of Quantification: Defines the range over which viral loads can be accurately measured without sample dilution.
• PCR Amplification Efficiency: Monitored via internal controls to ensure the enzymatic reaction proceeded without inhibition.
• Absence of PCR Inhibitors: Confirms that the blood sample did not contain substances that could interfere with the polymerase enzyme.
• Viral Suppression: Indicates a successful response to antiviral therapy when viral loads drop below detectable limits.
• Persistent Viremia: Highlights ongoing viral replication despite treatment, suggesting potential drug resistance.
• Occult Hepatitis B: Detects low levels of HBV DNA in patients who test negative for HBsAg but may still harbor the virus.
• Active Viral Replication Phase: Helps classify the clinical stage of chronic hepatitis (e.g., HBeAg-positive or HBeAg-negative chronic hepatitis).
• Inactive Carrier State: Confirms low or undetectable viral loads in asymptomatic patients with normal liver enzyme levels.
• Sample Adequacy: Ensures that the serum or plasma volume collected was sufficient for high-quality nucleic acid extraction.
• Contamination Control: Verifies that negative controls run alongside the patient sample show no amplification, ruling out laboratory contamination.
• Therapeutic Failure: Identified by an increase in viral load during an ongoing course of antiviral treatment.
• Risk Assessment for Cirrhosis: High viral loads of both viruses correlate directly with an accelerated rate of hepatic fibrogenesis.
• Risk Assessment for Hepatocellular Carcinoma: Helps stratify the long-term risk of developing liver cancer, which is significantly higher in dual infections.

Turnaround Time and Report Access at Dr. Essa Lab

At Dr. Essa Lab, we understand that timely diagnostic results are crucial for effective clinical decision-making and patient peace of mind. The HBV / HDV Multiplex PCR is a highly specialized molecular test that requires meticulous nucleic acid extraction, amplification, and quality control verification. Typically, the verified reports for this multiplex PCR test are completed and released within 3 to 5 working days from the time of sample collection.

Dr. Essa Lab offers multiple convenient methods for patients and referring physicians to access these critical diagnostic reports. Once the clinical pathologist signs off on the results, an automated SMS notification is sent to the patient’s registered mobile number. Reports can be securely downloaded online through the official Dr. Essa Lab web portal or via our dedicated mobile application. Additionally, patients can visit any of our conveniently located diagnostic centers across Karachi and other major cities to collect a printed, high-quality hard copy of their reports.

HBV / HDV Multiplex PCR Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
HBV DNA (Qualitative)	Not Detected	Detected (Indicates active HBV replication)
HBV DNA Viral Load (Quantitative)	Undetectable / Below LOD	Elevated viral load (e.g., >2,000 IU/mL to millions of IU/mL)
HDV RNA (Qualitative)	Not Detected	Detected (Indicates active HDV replication and co-infection/superinfection)
HDV RNA Viral Load (Quantitative)	Undetectable / Below LOD	Quantifiable viral load (indicates active delta virus replication and high disease activity)
Internal Control (PCR Amplification)	Amplified / Valid	Not Amplified / Invalid (Suggests presence of PCR inhibitors or extraction failure)
Serum ALT / AST Correlation	Within Normal Limits	Elevated liver enzymes (indicates active hepatocellular injury and inflammation)
Therapeutic Response	Undetectable Viral Load	Persistent or rising viral loads (indicates therapeutic failure or drug resistance)

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for HBV / HDV Multiplex PCR?

• Experienced Healthcare Professionals: Our molecular biology department is staffed by highly qualified pathologists, molecular biologists, and technologists specializing in viral diagnostics.
• Patient-Focused Care: We prioritize patient comfort, safety, and confidentiality throughout the entire testing process, from phlebotomy to report delivery.
• Quality Diagnostic Services: Dr. Essa Lab adheres to stringent international quality control standards, ensuring the highest level of diagnostic accuracy and reproducibility.
• Professional Reporting: Our reports are structured to provide clear, comprehensive, and clinically actionable quantitative data for treating physicians.
• Modern Diagnostic Approach: We utilize advanced real-time PCR platforms and state-of-the-art nucleic acid extraction systems to minimize human error and optimize sensitivity.
• Comfortable Environment: All our diagnostic centers are designed to offer a clean, hygienic, and welcoming environment for patients of all ages.
• Convenient Location: With an extensive network of collection centers across Karachi and beyond, patients can easily access our services close to home.
• Commitment to Accurate Diagnosis: We are dedicated to providing reliable, evidence-based diagnostic insights that play a pivotal role in managing complex infectious diseases.